Amyotrophic Lateral Sclerosis and Oral Health

Article English OPEN
Shah, Aakash; Shah, Purvesh; Goje, Santosh Kumar; Shah, Romil; Modi, Bhumi;
(2017)

Amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease is a progressive degenerative disorder that affects the nervous system, particularly the motor neurons. It may affect either spinal or bulbar neurons, which classify how symptoms present i... View more
  • References (37)
    37 references, page 1 of 4

    Shah, A., Shah, P., Goje, S., Shah, R., & Modi, B. (2017). Amyotrophic Lateral Sclerosis and Oral Health.Advanced Journal Of Graduate Research, 3(1), 13-19. doi: https://doi.org/10.21467/ajgr.3.1.13-19 R. Spataro, M. L. Re, T. Piccoli, F. Piccoli, and V. L. Bella, “Causes and place of death in Italian patients with amyotrophic lateral sclerosis,” Acta Neurologica Scandinavica, vol. 122, no. 3, pp. 217-223, 2010.

    F. A. Scannapieco, R. B. Bush, and S. Paju, “Associations Between Periodontal Disease and Risk for Nosocomial Bacterial Pneumonia and Chronic Obstructive Pulmonary Disease. A Systematic Review,” Annals of Periodontology, vol. 8, no. 1, pp. 54-69, 2003.

    J. M. Cedarbaum and N. Stambler, “Disease status and use of ventilatory support by ALS patients,” Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, vol. 2, no. 1, pp. 19-22, 2001.

    L. P. Rowland, “How Amyotrophic Lateral Sclerosis Got Its Name,” Archives of Neurology, vol. 58, no. 3, Jan. 2001.

    A. D. Walling, “Amyotrophic lateral sclerosis: Lou Gehrig's disease,” American family physician, vol. 59, no. 6, pp. 1489-1496, 1999.

    Debelleroche, “Clinical and functional investigation of 10 missense mutations and a novel frameshift insertion mutation of the gene for copper-zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis,” Neurology, vol. 48, no. 3, pp. 746-751, Jan.

    41, no. 2, pp. 210-221, 1997.

    A. Cifra, F. Nani, and A. Nistri, “Riluzole is a potent drug to protect neonatal rat hypoglossal motoneurons in vitro from excitotoxicity due to glutamate uptake block,” European Journal of Neuroscience, vol. 33, no. 5, pp. 899-913, 2011.

    K. M. Kurian, R. B. Forbes, S. Colville, and R. J. Swingler, “Cause of death and clinical grading criteria in a cohort of amyotrophic lateral sclerosis cases undergoing autopsy from the Scottish Motor Neurone Disease Register,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 80, no. 1, pp. 84-87, 2008.

    P. Corcia, P. F. Pradat, F. Salachas, G. Bruneteau, N. L. Forestier, D. Seilhean, J. J. Hauw, and V. Meininger, “Causes of death in a post‐mortem series of ALS patients,” Amyotrophic Lateral Sclerosis, vol. 9, no. 1, pp. 59-62, 2008.

  • Metrics
Share - Bookmark